HC Wainwright Has Positive Estimate for RIGL Q2 Earnings
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Analysts at HC Wainwright lifted their Q2 2025 earnings per share (EPS) estimates for Rigel Pharmaceuticals in a research note issued to investors on Wednesday, May 7th. HC Wainwright analyst J. Pantginis now expects that the biotechnology company will earn $2.52 per share for the quarter, up […]
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Analysts at HC Wainwright lifted their Q2 2025 earnings per share (EPS) estimates for Rigel Pharmaceuticals in a research note issued to investors on Wednesday, May 7th. HC Wainwright analyst J. Pantginis now expects that the biotechnology company will earn $2.52 per share for the quarter, up […]
